Hib-DTaP-hepatitis-B vaccine (Sanofi Pasteur)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameHib-DTaP-hepatitis-B vaccine (Sanofi Pasteur)
Drug Alias NameDTaP-HepB-Hib-sanofi pasteurDTaP-HB-PRP-TUnifive
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHepatitis BInfluenza, HumanTetanus +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPhilippines
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi Pasteur
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi Pasteur
Active IndicationsN/A
Inactive IndicationsHepatitis BInfluenza, HumanTetanus +[6] 

Other Information

ATC CodeN/A
Related LinksN/A